首页> 外国专利> RECOMBINANT PLASMID pAg85A-CBD, Escherichia coli pREP4, pAg85A-CBD STRAIN, CHIMERIC PROTEIN Ag85A-CBD AND THEIR APPLICATION

RECOMBINANT PLASMID pAg85A-CBD, Escherichia coli pREP4, pAg85A-CBD STRAIN, CHIMERIC PROTEIN Ag85A-CBD AND THEIR APPLICATION

机译:重组质粒pAg85A-CBD,大肠杆菌[pREP4,pAg85A-CBD]菌株,嵌合蛋白Ag85A-CBD及其应用

摘要

FIELD: medicine.;SUBSTANCE: synthetic gene Ag85A Mycobacterium tuberculosis optimised for heterologous expression in nonpathogenic laboratory strains. The recombinant plasmid pAg85A-CBD consisting of an artificial bacterial operon of chimeric protein containing a promotor area of an early promotor of bacteriophage T5, chimeric protein gene and transcription terminator, a bacterial operon of beta-lactamase and a bacterial ColEl-type replication initiation site is produced. The invention also involves the Escherichia coli strain producing chimeric protein Ag85A-CBD, and also a method of immobilisation, concentration and cellulose purification of produced protein. Besides, the invention refers to the same recombinant protein Ag85A-CBD and an immunogenic composition containing it and used for tuberculous infection immunity induction.;EFFECT: invention allows preparing the producer strain providing a high production level of resistant immunogenic proteins which can be one-stage produced, immobilised and purified, producing the effective immunogenic compositions for tuberculosis.;7 cl, 2 dwg, 5 ex
机译:领域:医学;研究对象:合成基因Ag85A结核分枝杆菌经过优化,可在非致病性实验室菌株中进行异源表达。重组质粒pAg85A-CBD由嵌合蛋白的人工细菌操纵子组成,该操纵子包含噬菌体T5的早期启动子的启动子区域,嵌合蛋白基因和转录终止子,β-内酰胺酶的细菌操纵子和细菌ColEl型复制起始位点被生产。本发明还涉及产生嵌合蛋白Ag85A-CBD的大肠杆菌菌株,以及产生的蛋白的固定化,浓缩和纤维素纯化的方法。此外,本发明涉及相同的重组蛋白Ag85A-CBD和包含该重组蛋白的免疫原性组合物,并用于结核感染免疫诱导。效果:本发明允许制备提供高生产水平的抗性免疫原性蛋白的生产菌株,其可以是-阶段,固定和纯化,生产有效的结核病免疫原性组合物。; 7 cl,2 dwg,5 ex

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号